Skip to main content
  • Short DAPT at Least Non-Inferior to Standard DAPT, 2 Studies Show

    Bleeding significantly lower in patients receiving shorter DAPT

    Two large randomized studies in Asia show at least non-inferior results for patients receiving shorter dual antiplatelet therapy (DAPT) compared to standard, 12-month DAPT while showing significantly less bleeding in patients receiving shorter DAPT, according to results presented Monday at the American College of Cardiology Scientific Sessions 2019 in New Orleans.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details